{"name":"Universidad de Guanajuato","slug":"universidad-de-guanajuato","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Antiseptic substantivity","genericName":"Antiseptic substantivity","slug":"antiseptic-substantivity","indication":"Oral antisepsis with prolonged antimicrobial activity","status":"phase_3"},{"name":"Chlorhexidine gluconate at 0.12%","genericName":"Chlorhexidine gluconate at 0.12%","slug":"chlorhexidine-gluconate-at-0-12","indication":"Oral rinse for reduction of plaque and gingivitis","status":"phase_3"},{"name":"Chlorhexidine gluconate at 0.125%","genericName":"Chlorhexidine gluconate at 0.125%","slug":"chlorhexidine-gluconate-at-0-125","indication":"Other","status":"marketed"},{"name":"Glargine and Lispro insulin","genericName":"Glargine and Lispro insulin","slug":"glargine-and-lispro-insulin","indication":"Other","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Chlorhexidine gluconate at 2%","genericName":"Chlorhexidine gluconate at 2%","slug":"chlorhexidine-gluconate-at-2","indication":"Oral antimicrobial rinse for plaque and gingivitis prevention","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Linagliptin / Metformin Oral Tablet","genericName":"Linagliptin / Metformin Oral Tablet","slug":"linagliptin-metformin-oral-tablet","indication":"Type 2 diabetes mellitus","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"chlorhexidine in isopropyl alcohol","genericName":"chlorhexidine in isopropyl alcohol","slug":"chlorhexidine-in-isopropyl-alcohol","indication":"Skin antisepsis and preoperative skin preparation","status":"phase_3"}]}],"pipeline":[{"name":"Antiseptic substantivity","genericName":"Antiseptic substantivity","slug":"antiseptic-substantivity","phase":"phase_3","mechanism":"Antiseptic substantivity refers to the prolonged antimicrobial activity of an antiseptic agent that persists on oral tissues after application.","indications":["Oral antisepsis with prolonged antimicrobial activity"],"catalyst":""},{"name":"Chlorhexidine gluconate at 0.12%","genericName":"Chlorhexidine gluconate at 0.12%","slug":"chlorhexidine-gluconate-at-0-12","phase":"phase_3","mechanism":"Chlorhexidine gluconate is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, leading to rapid bactericidal and bacteriostatic effects.","indications":["Oral rinse for reduction of plaque and gingivitis","Antimicrobial oral care in Phase 3 development"],"catalyst":""},{"name":"Chlorhexidine gluconate at 0.125%","genericName":"Chlorhexidine gluconate at 0.125%","slug":"chlorhexidine-gluconate-at-0-125","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Chlorhexidine gluconate at 2%","genericName":"Chlorhexidine gluconate at 2%","slug":"chlorhexidine-gluconate-at-2","phase":"phase_3","mechanism":"Chlorhexidine gluconate is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, leading to rapid bactericidal and bacteriostatic effects.","indications":["Oral antimicrobial rinse for plaque and gingivitis prevention","Topical antiseptic for wound irrigation and skin antisepsis","Oral care in immunocompromised patients"],"catalyst":""},{"name":"Glargine and Lispro insulin","genericName":"Glargine and Lispro insulin","slug":"glargine-and-lispro-insulin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Linagliptin / Metformin Oral Tablet","genericName":"Linagliptin / Metformin Oral Tablet","slug":"linagliptin-metformin-oral-tablet","phase":"marketed","mechanism":"Linagliptin inhibits dipeptidyl peptidase-4 (DPP-4) to increase incretin levels, while metformin reduces hepatic glucose production and improves insulin sensitivity, together lowering blood glucose in type 2 diabetes.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"chlorhexidine in isopropyl alcohol","genericName":"chlorhexidine in isopropyl alcohol","slug":"chlorhexidine-in-isopropyl-alcohol","phase":"phase_3","mechanism":"Chlorhexidine disrupts bacterial cell membranes and inhibits metabolic processes, providing broad-spectrum antimicrobial activity.","indications":["Skin antisepsis and preoperative skin preparation","Wound irrigation and disinfection","Oral rinse for plaque and gingivitis prevention"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBNUlRsRXFHSzE0eUM5d1F0TjFhblJjU04xWVpQOXJjVFVmZTNSTDViWFU1R1NhazEwajdueThBVU9wWDRoeFlBVWo5VkpWVGotOXBWbEJqam5Wc2d1cW9qaXd6NlNhMEtXaGVFYjBSTU94VEoteElvNXRBZmItQQ?oc=5","date":"2009-05-05","type":"pipeline","source":"PBS","summary":"Culture of Avoiding the Doctor Intensifies Health Concerns in Mexico - PBS","headline":"Culture of Avoiding the Doctor Intensifies Health Concerns in Mexico","sentiment":"neutral"}],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":4,"marketed":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}